Gene · 6613
Papers2,290
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
681 to 700 of 2,290
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A disease-causing mutation K240E disrupts ferroportin trafficking by SUMO (ferroportin SUMOylation). | Biochem Biophys Rep | 2021 | 33490642 | PubTator, text mining | PubMed |
| Transient deSUMOylation of IRF2BP proteins controls early transcription in EGFR signaling. | EMBO Rep | 2021 | 33480129 | PubTator, text mining | PubMed |
| SUMO-Activating Enzyme Subunit 1 (SAE1) Is a Promising Diagnostic Cancer Metabolism Biomarker of Hepatocellular Carcinoma. | Cells | 2021 | 33477333 | PubTator, text mining | PubMed |
| Proteome-wide identification of NEDD8 modification sites reveals distinct proteomes for canonical and atypical NEDDylation. | Cell Rep | 2021 | 33472076 | PubTator, text mining | PubMed |
| Phase separation and DAXX redistribution contribute to LANA nuclear body and KSHV genome dynamics during latency and reactivation. | PLoS Pathog | 2021 | 33471863 | PubTator, text mining | PubMed |
| The C-degron pathway eliminates mislocalized proteins and products of deubiquitinating enzymes. | EMBO J | 2021 | 33469951 | PubTator, text mining | PubMed |
| PIAS1 modulates striatal transcription, DNA damage repair, and SUMOylation with relevance to Huntington's disease. | Proc Natl Acad Sci U S A | 2021 | 33468657 | PubTator, text mining | PubMed |
| Alternative lengthening of telomeres is a self-perpetuating process in ALT-associated PML bodies. | Mol Cell | 2021 | 33453166 | PubTator, text mining | PubMed |
| SUMO mediated regulation of transcription factors as a mechanism for transducing environmental cues into cellular signaling in plants. | Cell Mol Life Sci | 2021 | 33452901 | PubTator, text mining | PubMed |
| Understanding COVID-19 Pandemic: Molecular Mechanisms and Potential Therapeutic Strategies. An Evidence-Based Review. | J Inflamm Res | 2021 | 33447071 | PubTator, text mining | PubMed |
| Identification of novel anti-tumor therapeutic target via proteomic characterization of ubiquitin receptor ADRM1/Rpn13. | Blood Cancer J | 2021 | 33441535 | PubTator, text mining | PubMed |
| SUMOylation mediates CtIP's functions in DNA end resection and replication fork protection. | Nucleic Acids Res | 2021 | 33406258 | PubTator, text mining | PubMed |
| Identification of PIM1 substrates reveals a role for NDRG1 phosphorylation in prostate cancer cellular migration and invasion. | Commun Biol | 2021 | 33398037 | PubTator, text mining | PubMed |
| SUMOylation of α-tubulin is a novel modification regulating microtubule dynamics. | J Mol Cell Biol | 2021 | 33394042 | PubTator, text mining | PubMed |
| Predicting changes in renal metabolism after compound exposure with a genome-scale metabolic model. | Toxicol Appl Pharmacol | 2021 | 33387578 | PubTator, text mining | PubMed |
| The ubiquitin ligase RFWD3 is required for translesion DNA synthesis. | Mol Cell | 2021 | 33321094 | PubTator, text mining | PubMed |
| SUMOylation is essential for Sirt2 tumor-suppressor function in neuroblastoma. | Neoplasia | 2021 | 33316537 | PubTator, text mining | PubMed |
| Dioscin alleviates hashimoto's thyroiditis by regulating the SUMOylation of IRF4 to promote CD4+CD25+Foxp3+ treg cell differentiation. | Autoimmunity | 2021 | 33274645 | PubTator, text mining | PubMed |
| Small ubiquitin-related modifier 2 affects the intracellular survival of Brucella abortus 2308 by regulating activation of the NF-κB pathway. | Innate Immun | 2021 | 33241964 | PubTator, text mining | PubMed |
| SUMO modification in apoptosis. | J Mol Histol | 2021 | 33225418 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6613/papers?page=35